EDESA BIOTECH, INC. Operating Lease, Liability, Noncurrent
EDESA BIOTECH, INC. (EDSA) had Operating Lease, Liability, Noncurrent of $0 as of 2024-09-30, per its 10-K filed 2024-12-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2024-12-13
- 2024-09-30: Operating Lease, Liability, Noncurrent $0.00.
- 2024-06-30: Operating Lease, Liability, Noncurrent $0.00.
- 2024-03-31: Operating Lease, Liability, Noncurrent $0.00.
- 2023-12-31: Operating Lease, Liability, Noncurrent $0.00.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2024-09-30 | $0.00 10-K · filed 2024-12-13 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 |
| 2023-12-31 | $0.00 10-Q · filed 2024-02-09 |
| 2023-09-30 | $19.77K 10-K · filed 2024-12-13 |
| 2023-06-30 | $40.08K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $64.42K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $76.62K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $0.00 10-K · filed 2023-12-15 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 |
| 2021-12-31 | $0.00 10-Q · filed 2022-02-14 |
| 2021-09-30 | $20.51K 10-K · filed 2022-12-16 |
| 2021-06-30 | $41.73K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $61.13K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $79.92K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $94.46K 10-K · filed 2021-12-28 |
| 2020-06-30 | $110.17K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $122.74K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $151.51K 10-Q · filed 2020-02-13 |
| 2019-09-30 | $0.00 10-K · filed 2020-12-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |